Medications for Bronchitis

Basically there are two types of bronchitis, acute and chronic bronchitis. Acute bronchitis is a short term illness that becomes more common during cold weather. It is usually followed by viral infection and can be associated with bacterial infections. Acute bronchitis usually clears itself within 2 weeks, but the cough may continue. And in some cases of acute bronchitis it can develop into pneumonia.

  

Infants and very young children, with underdeveloped immune systems and elderly who have weaker immune systems because of ageing, are more susceptible to acute bronchitis. Smokers and those with pre-existing lung and heart problems are also at risk in having acute bronchitis. People who are exposed to too much pollution are also more prone to this condition.

Chronic bronchitis is a respiratory illness where in the respiratory tract is also inflamed but in this case, it is accompanied with over secretion of mucus and coughing. The signs and symptoms can also last for a longer period of time. Chronic bronchitis can be caused by airway irritants including cigarette smoking and air pollution. This condition develops slowly, that is why middle aged and elderly individuals are most commonly diagnosed as having chronic bronchitis.

The main purpose of treating acute and chronic bronchitis is to lessen the signs and symptoms. For acute bronchitis, treatment may only consist of taking a lot of fluids, getting enough rest, installing humidifiers in the house, and stopping smoking. Medications are prescribed only when there is fever and pain, the most common is aspirin or Tylenol. Aspirin is contraindicated with very young children because it may result in Reye's syndrome and for pregnant women it may cause bleeding.

Medication for cough is only prescribed when patient has a dry cough or cough without phlegm. Expectorants are a common medication that can thin out hard mucus for easier coughing. But if the cough has phlegm, cough suppressants are not usually recommended, it will eventually comes out. If the phlegm is suppressed within the air passage, there will be an obstruction and it may become breeding area for dangerous microorganism.

However if the patient is diagnosed with bronchitis associated with bacterial infection, antibiotics are prescribed. Taking antibiotics must be done as prescribed, if not, it may worsen the illness or there may be antibiotic resistance. Common antibiotics prescribed are, Azithromycin, trimethoprim or sulfamethazole, clarithromycin, tetracycline or ampicillin and amoxicillin.

Treatment for Chronic bronchitis is more complex, the patient will be evaluated for other health problems first before proceeding with treating chronic bronchitis. Medications for chronic bronchitis include, anti-inflammatory drugs like corticosteroids and Ipratropium. Bronchodilator medications are also prescribed to relax bronchial muscles to increase air flow. These can be taken orally or through a nebulizer. These include metaproterenol and albuterol.

In addition to conventional medicine, herbal medication may be prescribed for bronchitis. It can be in the form of a tea or it can be inhaled. The chronic bronchitis patient may eventually require the need for supplemental oxygen. And if the situation gets worse the patient should be taken to the hospital, so doctors can treat and monitor the condition.



   

Bronchitis Recommended Products


Bacterial Bronchitis Headlines

Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV

Ligand Pharmaceuticals Incorporated announced today that its partner Rib-X Pharmaceuticals, Inc. has initiated a Phase 3 clinical trial of a Captisol-enabled™ intravenous formulation of delafloxacin for the first-line treatment of acute bacterial skin and skin structure infections , including infections caused by MRSA.

Read more...


Rib-X Pharmaceuticals Initiates Delafloxacin Global Phase 3 Clinical Trial in Patients with Acute Bacterial Skin and ...

Rib-X Pharmaceuticals, Inc., today announced the initiation of a Phase 3 clinical trial evaluating delafloxacin, the company’s lead antibiotic, in patients with acute bacterial skin and skin structure infections .

Read more...


FDA Cautions Against Antibiotics for People with Heart Problems

An antibiotic commonly prescribed for bronchitis and sinus infections may increase the risk of death from heart problems, but only for people with certain risk factors, a new study suggests.

Read more...


FDA cautions against antibiotics for heart patients

By Rachael Rettner, MyHealthNewsDaily An antibiotic commonly prescribed for bronchitis and sinus infections may increase the risk of death from heart problems, but only for people with certain risk factors, a new study suggests. The study involved more than a million cases of antibiotic treatment for young and middle-age adults living in Denmark. Use of the antibiotic azithromycin was linked ...

Read more...


Monolaurin: A Wonder Immune Boosting Component

MUMBAI, India, May 15, 2013 /PRNewswire/ -- An active component of lauric acid, monolaurin shows promising anti - microbial results Coconut oil is the second best source after mother's milk A workshop ...

Read more...



Sponsored Links

 

 

 

Site Navigation